Response Pharmaceuticals, Inc. — Form D/A
Response Pharmaceuticals, Inc. of FALLS CHURCH, VA, a company, filed a Form D amendment with the SEC on 2022-12-05. The offering totals $8.0M, of which $8.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2022-12-05
- Form: D/A
- Accession: 0001913970-22-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $8.0M
- Amount sold: $8.0M
- Remaining: $12K
- Minimum investment: $20K
- Investors: 127
- Date of first sale: 2022-02-08
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-435425
Issuer
- Name: Response Pharmaceuticals, Inc.
- CIK: 0001913970
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 1104 WEST BROAD STREET #1064, FALLS CHURCH, VA, 22046
- Phone: 703-624-2024
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Paul Sweetnam | Executive Officer | McLean, VA |
| Eric Keller | Director | McLean, VA |
| Eric Keller | Executive Officer | McLean, VA |
| Michael Berendt | Director | McLean, VA |
| Donald Olds | Director | McLean, VA |
Other filings by this issuer (2)
More